MedPath

UNIVERSITY OF MIAMI

UNIVERSITY OF MIAMI logo
🇺🇸United States
Ownership
Private
Established
1925-01-01
Employees
10K
Market Cap
-
Website
https://continue.miami.edu/packagedetail.aspx

The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation

Not Applicable
Withdrawn
Conditions
Constipation-predominant Irritable Bowel Syndrome
Constipation - Functional
Constipation
Constipation by Outlet Obstruction
Interventions
Other: Standard Physical Therapy Care
Other: Aerobic and Inspiratory Muscle Training
First Posted Date
2022-04-11
Last Posted Date
2023-05-12
Lead Sponsor
University of Miami
Registration Number
NCT05321953
Locations
🇺🇸

University of Miami, Coral Gables, Florida, United States

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

Phase 2
Completed
Conditions
Chemotherapy-induced Nausea and Vomiting
Interventions
Drug: Standard of Care Treatment for Chemotherapy Induced Nausea and Vomiting (CINV)
Drug: Aromatherapy Care
First Posted Date
2022-04-08
Last Posted Date
2025-04-17
Lead Sponsor
University of Miami
Target Recruit Count
100
Registration Number
NCT05319860
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Pain and Hysteroscopy

Not Applicable
Completed
Conditions
Hysteroscopy Surgery
Interventions
Other: Objective Descriptive Language
Other: Anticipated Discomfort Language
First Posted Date
2022-04-07
Last Posted Date
2023-09-26
Lead Sponsor
University of Miami
Target Recruit Count
70
Registration Number
NCT05316506
Locations
🇺🇸

University of Miami Hospital, Miami, Florida, United States

Exercise Induced Hypoalgesia Diabetes

Not Applicable
Withdrawn
Conditions
Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathy
Interventions
Other: Moderate Cycling
Other: Personalized Tourniquet System
First Posted Date
2022-03-25
Last Posted Date
2022-05-25
Lead Sponsor
University of Miami
Registration Number
NCT05296642
Locations
🇺🇸

University of Miami Miller School of Medicine, Miami, Florida, United States

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

Phase 2
Recruiting
Conditions
Marginal Zone Lymphoma
Interventions
Drug: Loncastuximab tesirine 150 µg/Kg
Drug: Loncastuximab tesirine 75µg/Kg
First Posted Date
2022-03-25
Last Posted Date
2025-05-21
Lead Sponsor
University of Miami
Target Recruit Count
50
Registration Number
NCT05296070
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

🇺🇸

City of Hope National Medical Center, Duarte, California, United States

and more 1 locations

Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)

Phase 3
Completed
Conditions
Total Hip Replacement
Total Knee Replacement
Interventions
First Posted Date
2022-03-22
Last Posted Date
2024-08-14
Lead Sponsor
University of Miami
Target Recruit Count
223
Registration Number
NCT05291598
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Not Applicable
Recruiting
Conditions
Recurrent Glioblastoma
Interventions
Radiation: Intensity Modulated Proton Therapy (IMPT)
First Posted Date
2022-03-17
Last Posted Date
2024-08-21
Lead Sponsor
University of Miami
Target Recruit Count
96
Registration Number
NCT05284643
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Gastroparesis in Cystic Fibrosis

Not Applicable
Withdrawn
Conditions
Gastroparesis
Interventions
Device: 13^C Spirulina Platensis Gastric Emptying Breath Test (GEBT)
First Posted Date
2022-02-04
Last Posted Date
2022-05-02
Lead Sponsor
University of Miami
Registration Number
NCT05223881

Tele-Harm Reduction

Not Applicable
Active, not recruiting
Conditions
IV Drug Usage
Hepatitis C
HIV Infections
Interventions
Behavioral: Tele-Harm Reduction
Other: off-site linkage
First Posted Date
2022-01-26
Last Posted Date
2025-03-10
Lead Sponsor
University of Miami
Target Recruit Count
100
Registration Number
NCT05208697
Locations
🇺🇸

Care Resource The SPOT, Fort Lauderdale, Florida, United States

🇺🇸

University of South Florida, Tampa, Florida, United States

🇺🇸

University of Miami, Miami, Florida, United States

and more 3 locations

Laser Treated Scars and Optical Coherence Tomography (OCT)

Not Applicable
Withdrawn
Conditions
Scar
First Posted Date
2021-12-21
Last Posted Date
2024-02-20
Lead Sponsor
University of Miami
Registration Number
NCT05166395
Locations
🇺🇸

University of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath